A small 2023 study found that GLP-1 use in women with PCOS led to improved menstrual regularity after 12 weeks of treatment
Our medical weight loss program is designed to meet your unique needs with scientifically proven treatments like Tirzepatide and Semaglutide, supported by award-winning products and cutting-edge technology
This is why a primary concern with microdosing is that people may not obtain the necessary amount of the GLP-1 drug to have the desired therapeutic outcome, such as weight loss
Gallbladder Issues Rapid weight loss and the medication itself can sometimes lead to gallstones or gallbladder inflammation
cConcentration of the analyte in the final sample solution, in micrograms per milliliter (g/mL)
Atkin, Postgraduate Medical Institute & Hull York Medical School, University of Hull, United Kingdom Received: August 17, 2013